Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cytokines in cerebrospinal fluid as a prognostic predictor after treatment of nusinersen in SMA patients

Published:2024-09 Issue: Volume:244 Page:108462
ISSN:0303-8467
Container-title:Clinical Neurology and Neurosurgery
language:en
Short-container-title:Clinical Neurology and Neurosurgery

Author:

Cheng Xi,Li Ya-Nan,Fan Ya-Bei,Zhao Hui-Hui,Li Ling,Lu Chao,Zhu Liang-Hua,Niu Qi

Funder

Jiangsu Province Natural Science Foundation

Jiangsu Province Hospital

Nanjing Medical University

Foundation for Innovative Research Groups of the National Natural Science Foundation of China

Publisher

Elsevier BV

Reference35 articles.

1. Spinal muscular atrophy;Mercuri;Nat. Rev. Dis. Prim.,2022

2. Two-year efficacy and safety of risdiplam in patients with type 2 or non-ambulant type 3 spinal muscular atrophy (SMA);Oskoui;J. Neurol.,2023

3. Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study;Bitetti;Gene Ther.,2022

4. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial;Masson;Lancet Neurol.,2022

5. Effect of nusinersen on motor, respiratory and bulbar function in early-onset spinal muscular atrophy;Pechmann;Brain,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP